TraceLink Propels Organizations Toward DSCSA Compliance Ahead of the November 2024 Deadline
BOSTON, Sept. 27, 2024 /PRNewswire/ -- With the Drug Supply Chain Security Act (DSCSA) stabilization period ending on November 27, 2024,...
Month: September 2024
Ping An Healthcare and Technology Stock Soared 10% – Managed Care Takes Center Stage in Corporate Health Management
SHANGHAI, Sept. 27, 2024 /PRNewswire/ -- On September 26, 2024, Ping An Healthcare and Technology Company Limited ("Ping An Good...
CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest addition to its enterprise...
Encinitas Dentist Dr. Justin Smith Elevates Dental Care with Innovative 3D Printing at Cliffside Family Dentistry
ENCINITAS, Calif., Sept. 27, 2024 /PRNewswire/ -- Cliffside Family Dentistry is now offering 3D printing technology to improve the accuracy...
Axtria Recognized for Excellence in AI with a Minsky Award at Cypher 2024
Axtria's GenAI innovations were recognized at India's most prestigious AI awards for driving operational excellence and transforming solutions for life...
Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024
RADNOR, Pa., Sept. 27, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services...
Mercy Executive Named Among Top Data/AI Leaders in Nation
ST. LOUIS, Sept. 27, 2024 /PRNewswire/ -- Mercy's industry-leading work in data and artificial intelligence has placed Byron Yount, PhD, chief...
Alpha Omega wins Best Digital Transformation Award at Unqork + AI Hackathon
VIENNA, Va., Sept. 27, 2024 /PRNewswire/ -- Alpha Omega, a leader in mission-focused technology solutions, proudly announces that we have been awarded...
Epic calls on Particle Health to approve release of resolution in patient privacy dispute
VERONA, Wis., Sept. 27, 2024 /PRNewswire/ -- Epic and our customers protect the privacy of many Americans' health data. At...
Hyivy Health Secures $2M Seed to Unlock New Model for Treating Pelvic Pain
Pelvic health startup Hyivy Health poised to offer better solutions to the 300M patients with pelvic floor dysfunction causing chronic...
Patients for Patient Safety US Applauds the Biden-Harris Administration for Prioritizing Patient Safety
WASHINGTON, DC / ACCESSWIRE / September 27, 2024 / On September 17th, World Patient Safety Day (WPSD), the Biden-Harris Administration...
Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3
First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral format KELOWNA, BC / ACCESSWIRE / September 27,...
Introducing Compassion Center Austin: Pioneering Natural Wellness Solutions Through the Texas Compassionate Use Program (TCUP)
Compassion Center Austin introduces Texans to natural pain management and opioid risk reduction through the Texas Compassionate Use Program (TCUP)....
Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion
WARSAW, POLAND / ACCESSWIRE / September 27, 2024 / Humaneva Inc. has entered into a significant investment agreement with Viking...
MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024
Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic painMIAMI, FL / ACCESSWIRE / September 27, 2024...
Burning Rock Announces Changes to Management and Board of Directors
GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a...
Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company...
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical...
Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day
Announces completion of enrollment in its oral allergen challenge study for the development of its late-stage pipeline program, Anaphylm™ (epinephrine)...
TALVEY®▼ (talquetamab) and DARZALEX® (daratumumab) subcutaneous (SC) formulation-based combination shows deep and durable responses in patients with relapsed or refractory multiple myeloma
Updated data show 100 percent overall response rate, with 56 percent of patients achieving complete response or better with weekly...